Cardiac amyloidosis
RecruitingStudy on the Effects of Valsartan and Sacubitril for Patients with Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction
Study on the Effects of Valsartan and Sacubitril for Patients with Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction
- Disease:Cardiac amyloidosis
- Substances:SacubitrilValsartan
Spain- Participants:18–64 years · 65+ years
- Substances:Sacubitril
- Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda












